Boston Foundation, Inc., 10% Owner at Flex Pharma, Inc. (FLKS), sold 1,600,000 shares at $0.33 ($528K) on 2019-01-30, disclosed to the SEC on 2019-02-05.
Open-market sale of $528k FLKS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |